My researches focus on the cellular and molecular mechanisms of acute lung injury, especially during lung transplantation. We also identify new drugs and new drug delivery systems with nanotechnology. My expertise on intracellular signal transduction led to the delivery of novel gene, XB130 (also called AFAP1L2), which is an adaptor protein for cell proliferation, survival and migration.
Together with Dr. Shaf Keshajvee, I am co-lead the Thoracic Surgery Research Laboratories, which is one of the largest research team in lung transplantation. We invented new techniques for donor lung assessment and repair. Rapid molecular diagnostic tools are developed through large scale omics studies and nanotechnology.

I am also the Director of Institute of Medical Science, which as a large graduate units for clinical departments and teaching hospitals, with over 600 faculty members and similar number of graduate students.